EntryPoint Capital LLC bought a new stake in Bowhead Specialty Holdings Inc. (NYSE:BOW - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 10,585 shares of the company's stock, valued at approximately $376,000.
A number of other institutional investors have also made changes to their positions in BOW. Sei Investments Co. grew its position in shares of Bowhead Specialty by 0.8% during the 4th quarter. Sei Investments Co. now owns 94,395 shares of the company's stock worth $3,353,000 after buying an additional 760 shares during the period. New York State Common Retirement Fund acquired a new position in Bowhead Specialty in the fourth quarter valued at about $64,000. Corebridge Financial Inc. boosted its holdings in Bowhead Specialty by 49.9% during the fourth quarter. Corebridge Financial Inc. now owns 5,787 shares of the company's stock worth $206,000 after buying an additional 1,926 shares during the last quarter. US Bancorp DE bought a new stake in shares of Bowhead Specialty in the 4th quarter valued at about $76,000. Finally, The Manufacturers Life Insurance Company raised its position in shares of Bowhead Specialty by 5.2% in the 3rd quarter. The Manufacturers Life Insurance Company now owns 60,508 shares of the company's stock valued at $1,695,000 after acquiring an additional 2,976 shares during the period.
Analyst Ratings Changes
Separately, Keefe, Bruyette & Woods raised Bowhead Specialty from a "market perform" rating to an "outperform" rating and set a $44.00 price target on the stock in a research report on Monday, March 3rd. Two investment analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average target price of $33.60.
Get Our Latest Report on BOW
Insider Buying and Selling
In other Bowhead Specialty news, Director Ava Schnidman purchased 1,493 shares of the business's stock in a transaction on Friday, February 28th. The shares were purchased at an average cost of $33.41 per share, with a total value of $49,881.13. Following the transaction, the director now directly owns 1,893 shares of the company's stock, valued at $63,245.13. This represents a 373.25 % increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.
Bowhead Specialty Stock Down 1.1 %
Shares of BOW stock traded down $0.47 on Monday, hitting $41.69. 195,390 shares of the stock were exchanged, compared to its average volume of 192,430. Bowhead Specialty Holdings Inc. has a fifty-two week low of $22.14 and a fifty-two week high of $42.29. The business has a 50-day moving average of $34.20 and a 200 day moving average of $32.91.
Bowhead Specialty (NYSE:BOW - Get Free Report) last released its quarterly earnings results on Tuesday, February 25th. The company reported $0.42 earnings per share for the quarter, topping analysts' consensus estimates of $0.35 by $0.07. The firm had revenue of $184.77 million for the quarter, compared to analyst estimates of $102.12 million. On average, sell-side analysts anticipate that Bowhead Specialty Holdings Inc. will post 1.36 earnings per share for the current fiscal year.
Bowhead Specialty Company Profile
(
Free Report)
Bowhead Specialty Holdings Inc provides specialty property and casualty insurance products in the United States. It underwrites casualty insurance solutions for risks in the construction, distribution, heavy manufacturing, real estate, and hospitality segments; professional liability insurance solutions for financial institutions, private and public directors and officers liability insurance, errors and omissions liability insurance, and cyber segments; and healthcare solutions for hospitals, senior care providers, managed care organizations, miscellaneous medical facilities, and healthcare management liability segments.
Read More

Before you consider Bowhead Specialty, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bowhead Specialty wasn't on the list.
While Bowhead Specialty currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.